Published in Nature on August 23, 2013
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2013) 12.36
CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol (2014) 9.18
Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell (2014) 5.26
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature (2014) 5.19
CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell (2014) 3.68
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol (2015) 3.56
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol (2014) 2.51
High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet (2015) 2.35
Using targeted chromatin regulators to engineer combinatorial and spatial transcriptional regulation. Cell (2014) 2.27
Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat Methods (2015) 2.22
Optogenetics: 10 years of microbial opsins in neuroscience. Nat Neurosci (2015) 1.85
A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol (2015) 1.83
Interpreting the language of histone and DNA modifications. Biochim Biophys Acta (2014) 1.80
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res (2014) 1.59
Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development (2014) 1.59
Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice. Nat Biotechnol (2014) 1.58
Optogenetic control of molecular motors and organelle distributions in cells. Chem Biol (2015) 1.51
Light-controlled modulation of gene expression by chemical optoepigenetic probes. Nat Chem Biol (2016) 1.49
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat Chem Biol (2015) 1.48
Illuminating cell signalling with optogenetic tools. Nat Rev Mol Cell Biol (2014) 1.46
Brave new epigenomes: the dawn of epigenetic engineering. Genome Med (2015) 1.46
Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat Rev Mol Cell Biol (2014) 1.41
A CRISPR view of development. Genes Dev (2014) 1.41
Crystal Structure of Staphylococcus aureus Cas9. Cell (2015) 1.40
Physical principles for scalable neural recording. Front Comput Neurosci (2013) 1.40
Wireless Optofluidic Systems for Programmable In Vivo Pharmacology and Optogenetics. Cell (2015) 1.40
Engineering an improved light-induced dimer (iLID) for controlling the localization and activity of signaling proteins. Proc Natl Acad Sci U S A (2014) 1.34
An optimized optogenetic clustering tool for probing protein interaction and function. Nat Commun (2014) 1.33
Rational design of a split-Cas9 enzyme complex. Proc Natl Acad Sci U S A (2015) 1.30
An optogenetic gene expression system with rapid activation and deactivation kinetics. Nat Chem Biol (2014) 1.30
Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res (2016) 1.27
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods (2015) 1.27
Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods (2016) 1.24
A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res (2015) 1.20
Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol (2015) 1.20
Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci (2015) 1.18
MicroRNA Expression Profile of Neural Progenitor-Like Cells Derived from Rat Bone Marrow Mesenchymal Stem Cells under the Influence of IGF-1, bFGF and EGF. Int J Mol Sci (2015) 1.15
Expanding the CRISPR imaging toolset with Staphylococcus aureus Cas9 for simultaneous imaging of multiple genomic loci. Nucleic Acids Res (2016) 1.14
Advances in genome editing technology and its promising application in evolutionary and ecological studies. Gigascience (2014) 1.11
A CRISPR/Cas9-based system for reprogramming cell lineage specification. Stem Cell Reports (2014) 1.09
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. Cancer Discov (2016) 1.08
A new era for functional labeling of neurons: activity-dependent promoters have come of age. Front Neural Circuits (2014) 1.07
Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies. Acc Chem Res (2014) 1.06
Functional interpretation of non-coding sequence variation: concepts and challenges. Bioessays (2013) 1.06
Optogenetic approaches to cell migration and beyond. Curr Opin Cell Biol (2014) 1.06
Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol (2016) 1.05
Development of an intein-mediated split-Cas9 system for gene therapy. Nucleic Acids Res (2015) 1.03
Chromatin regulation at the frontier of synthetic biology. Nat Rev Genet (2015) 1.01
Optogenetic control of intracellular signaling pathways. Trends Biotechnol (2014) 1.01
Photochemistry of flavoprotein light sensors. Nat Chem Biol (2014) 1.00
Optogenetics. Proc Natl Acad Sci U S A (2013) 0.99
Genetically encoded molecular probes to visualize and perturb signaling dynamics in living biological systems. J Cell Sci (2014) 0.99
Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity. Clin Epigenetics (2015) 0.99
Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat Biotechnol (2015) 0.98
Genetically encoded light-activated transcription for spatiotemporal control of gene expression and gene silencing in mammalian cells. J Am Chem Soc (2013) 0.98
Exciting prospects for precise engineering of Caenorhabditis elegans genomes with CRISPR/Cas9. Genetics (2013) 0.97
Cardiac applications of optogenetics. Prog Biophys Mol Biol (2014) 0.95
Reversible Optogenetic Control of Subcellular Protein Localization in a Live Vertebrate Embryo. Dev Cell (2016) 0.95
Correlating in Vitro and in Vivo Activities of Light-Inducible Dimers: A Cellular Optogenetics Guide. ACS Synth Biol (2015) 0.95
Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. ACS Synth Biol (2013) 0.94
Twenty-five years of progress: the view from NIMH and NINDS. Neuron (2013) 0.94
Beyond the hammer and the scalpel: selective circuit control for the epilepsies. Nat Neurosci (2015) 0.94
Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease. Cell Stem Cell (2015) 0.94
Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression. Methods (2014) 0.93
Focusing brain therapeutic interventions in space and time for Parkinson's disease. Curr Biol (2014) 0.93
A CRISPR-based approach for targeted DNA demethylation. Cell Discov (2016) 0.93
Natural photoreceptors as a source of fluorescent proteins, biosensors, and optogenetic tools. Annu Rev Biochem (2015) 0.92
Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain. Nucleic Acids Res (2014) 0.92
Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Res (2015) 0.92
Epigenome engineering in cancer: fairytale or a realistic path to the clinic? Front Oncol (2015) 0.92
Ultradian oscillations and pulses: coordinating cellular responses and cell fate decisions. Development (2014) 0.92
How might novel technologies such as optogenetics lead to better treatments in epilepsy? Adv Exp Med Biol (2014) 0.91
Control of Protein Activity and Cell Fate Specification via Light-Mediated Nuclear Translocation. PLoS One (2015) 0.91
Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity. Mol Cell (2016) 0.91
Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes. Sci Rep (2015) 0.90
Transcriptional and epigenetic regulation of Hebbian and non-Hebbian plasticity. Neuropharmacology (2014) 0.90
Enabling functional genomics with genome engineering. Genome Res (2015) 0.90
Optogenetics enlightens neuroscience drug discovery. Nat Rev Drug Discov (2015) 0.90
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer. Oncogene (2015) 0.89
TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery. Acta Naturae (2014) 0.89
DNA methylation and its implications and accessibility for neuropsychiatric therapeutics. Annu Rev Pharmacol Toxicol (2014) 0.89
Genetic and genomic tools for the marine annelid Platynereis dumerilii. Genetics (2014) 0.88
Resources for functional genomics studies in Drosophila melanogaster. Genetics (2014) 0.88
Architectural Representation of Valence in the Limbic System. Neuropsychopharmacology (2015) 0.88
The New State of the Art: Cas9 for Gene Activation and Repression. Mol Cell Biol (2015) 0.87
Optimized second-generation CRY2-CIB dimerizers and photoactivatable Cre recombinase. Nat Chem Biol (2016) 0.86
Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions. Nat Biotechnol (2016) 0.86
Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia. Schizophr Res (2014) 0.85
Algal photoreceptors: in vivo functions and potential applications. Planta (2013) 0.85
Genetics and Epigenetics of Eating Disorders. Adv Genomics Genet (2015) 0.85
Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells. Cell Stem Cell (2016) 0.85
Histone H3 globular domain acetylation identifies a new class of enhancers. Nat Genet (2016) 0.84
Hyperactivated Stat3 boosts axon regeneration in the CNS. Exp Neurol (2016) 0.83
Molecular neuroanatomy: a generation of progress. Trends Neurosci (2013) 0.83
Regulation of gene expression in the genomic context. Comput Struct Biotechnol J (2014) 0.83
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications. Mol Ther (2015) 0.83
TAL effectors: tools for DNA targeting. Brief Funct Genomics (2014) 0.83
Photo-activatable Cre recombinase regulates gene expression in vivo. Sci Rep (2015) 0.83
Photoreceptor engineering. Front Mol Biosci (2015) 0.83
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
Breaking the code of DNA binding specificity of TAL-type III effectors. Science (2009) 22.33
A simple cipher governs DNA recognition by TAL effectors. Science (2009) 19.99
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A (2012) 16.48
Multimodal fast optical interrogation of neural circuitry. Nature (2007) 14.68
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol (2011) 12.86
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol (2004) 10.60
Integrating mRNA processing with transcription. Cell (2002) 9.74
Pre-mRNA processing reaches back to transcription and ahead to translation. Cell (2009) 7.45
Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature (2009) 6.74
Optogenetics. Nat Methods (2010) 6.49
Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A (1998) 5.46
A light-switchable gene promoter system. Nat Biotechnol (2002) 5.28
Rapid blue-light-mediated induction of protein interactions in living cells. Nat Methods (2010) 4.70
Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc (2010) 4.69
Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun (2012) 3.60
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res (2013) 3.51
Photoexcited CRY2 interacts with CIB1 to regulate transcription and floral initiation in Arabidopsis. Science (2008) 3.44
Induction of protein-protein interactions in live cells using light. Nat Biotechnol (2009) 3.16
The microbial opsin family of optogenetic tools. Cell (2011) 2.94
Effect of genome size on AAV vector packaging. Mol Ther (2009) 2.77
A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science (2011) 2.77
TULIPs: tunable, light-controlled interacting protein tags for cell biology. Nat Methods (2012) 2.59
The signaling state of Arabidopsis cryptochrome 2 contains flavin semiquinone. J Biol Chem (2007) 2.23
Optogenetic protein clustering and signaling activation in mammalian cells. Nat Methods (2013) 2.22
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res (2012) 2.14
High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states. Nat Protoc (2013) 1.73
Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J Am Chem Soc (2012) 1.69
Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res (2012) 1.60
Production and titering of recombinant adeno-associated viral vectors. J Vis Exp (2011) 1.41
Engineering the ABA plant stress pathway for regulation of induced proximity. Sci Signal (2011) 1.35
Structural tuning of the fluorescent protein iLOV for improved photostability. J Biol Chem (2012) 1.19